
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Lake Bleu Capital is a Hong Kong-based investment platform that specializes in healthcare.
Investor Profile
Lake Bleu Capital has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 21% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series C, Series E rounds (top funding stages).
- Majority of deals are located in China, United States, Hong Kong.
- Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
Stage Focus
- Series D (21%)
- Series C (21%)
- Series E (14%)
- Post Ipo Equity (7%)
- Series B (7%)
- Private Equity (7%)
- Series A (7%)
- Series Unknown (7%)
- Seed (7%)
Country Focus
- China (71%)
- United States (21%)
- Hong Kong (7%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Therapeutics
- Medical
- Product Research
- Oncology
- Medical Device
- Artificial Intelligence (Ai)
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.